Index

• 1m
• 6m
• ytd
• 1y
• 3y
• 5y
• max

×

Index Methodology

Market Share

Select a Metric

• Fermentation Based API Products - Market Share (%)
• Gastrointestinal (Nurokind-LC) - Market Share (%)
• Depression (Placida) - Market Share (%)
• Anti-Hypertensives (Amolkind-AT) Market Share (%)
• Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
• Birth Control (Unwanted-72) - Market Share (%)
• Anti - Diabetes - Market Share (%)
• Anti-Infectives - Market Share (%)
• Cardiovascular - Market Share (%)
• Gastro-Intestinal - Market Share (%)
• Pharmaceutical Sector - Market Share (%)
• Sex Stimulants - Market Share (%)
• Vaccines - Market Share (%)
• Vitamin & Dietary Supplements - Market Share (%)

×

Index Methodology

Operational Metrics

• Sector
• Company

Select a Metric

• Pharma spend as a % of GDP - India (%)
• Pharma spend as a % of GDP - Korea (%)
• Pharma spend as a % of GDP - USA (%)
• Domestic Pharma - Monthly Sales (Crs)
• Domestic Pharma Price Growth (%)
• Domestic Pharma Volume Growth (%)
• Total ANDA's Approved by USFDA

Select a Metric

• No Of Pharmacies (.)
• Number of ANDA's Approved By USFDA (.)
• Number of ANDA's Filed in USA (.)
• Manufacturing Capacity - Metformin (MTPA)
• No of Pharmacy Outlets - Kolkata (.)
• Quarterly Sales Volume - Injectables (Nos)
• Quarterly Sales Volume - Nutraceuticals (Nos)
• Quarterly Sales Volume - Orals (Nos)
• Realization / Tonne - Piperazine (Rs/MT)
• Manufacturing Capacity - Pyridin-3-One (MTPA)
• Realization / Tonne - Pyridin-3-One (Rs/MT)
• Domestic Sales Growth - YoY (%)
• Number of ANDA's Approved (.)
• Number of ANDA's Filed in Europe
• Number of ANDA's Approved in Europe
• Canada DMF fillings (.)
• US DMF Filings (.)
• Australia DMF fillings (.)
• US DMF Approval (.)
• Europe DMF Filings (.)
• DMF Filingsby API (.)
• Total reactor capacity (kL)
• Global DMFs filed (.)
• APIs Production Capacity (MTPA)
• Japan DMF Filings (.)
• Realization - Tetralone (Rs/Tonne)
• Manufacturing Capacity - Omeprazole (MTPA)
• Capacity Utilization - Esomeprazole (%)
• Realization - Pantaprazole Sodium (Rs/Tonne)
• Capacity Utilization - Benzimidazole (%)
• Capacity Utilization - Omeprazole (%)
• Manufacturing Capacity - Benzimidazole (MTPA)
• Realization - Chloro Compound (Rs/Tonne)
• Manufacturing Capacity - Pantaprazole (MTPA)
• Realization - Op. Sulphide (Rs/Tonne)
• Realization - Esomeprazole Magnesium (Rs/Tonne)
• Capacity Utilization - Chloro Compound (%)
• Capacity Utilization - Pantaprazole (%)
• Realization - Benzimidazole (Rs/Tonne)
• Realization - Omeprazole Powder (Rs/Tonne)
• Manufacturing Capacity - Esomeprazole (MTPA)
• Manufacturing Capacity - Chloro Compound (MTPA)
• Realization - Ammonium Sulphate (Rs/Tonne)
• Manufacturing Capacity - Ibuprofen (MTPA)
• Capacity Utilization - Pharmaceuticals (%)
• Number of ANDA's Filed in Canada
• Number of ANDA's Approved by Canada
• Number of ANDA's Filed in Australia
• Number of ANDA's Approved by Australia
• Number of ANDA's Filed in South Africa
• Number of ANDA's Approved by South Africa
• Number of ANDA's Filed in Latam
• Number of ANDA's Approved by Latam
• Manufacturing Capacity - Piperazine (MTPA)
• Manufacturing Capacity - Paracetamol (MTPA)
• No of Pharmacy Outlets - Hyderabad (.)
• No of Pharmacy Outlets - Bangalore (.)
• No of Pharmacy Outlets - Chennai (.)

×

Index Methodology

Segments

Select a Metric

• Therapeutic wise Break-Up - Domestic Pharma (Crs)
• Dermatology (Crs)
• Cardiovascular (Crs)
• Blood Related (Crs)
• Antineo Plastic (Crs)
• Anti-Malarial (Crs)
• Anti - Infectives (Crs)
• Vaccines (Crs)
• Stomatological (Crs)
• Sex Stimulants (Crs)
• Respiratory (Crs)
• Pain (Crs)
• Others (Crs)
• Ophthalmology (Crs)
• Neurological (Crs)
• Gynecology (Crs)
• Gastro-Intestinal (Crs)
• Endocrinology (Crs)
• Urology (Crs)
• Vitamin & Dietary Supplements (Crs)
• Anti - Diabetes (Crs)
• Indian vs MNC - Domestic Share (Crs)
• Indian (Crs)
• MNC (Crs)

Export Import Data

• 1y
• 2y
• 3y
• 5y
• 10y

Select a Metric

• Pharmaceutical Products (Kgs)